These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8643194)

  • 1. Calcitriol and calcium carbonate therapy in early chronic renal failure.
    Brown CB
    Nephrol Dial Transplant; 1995 Nov; 10(11):2158-9. PubMed ID: 8643194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
    Novikov AI
    Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcitriol and calcium carbonate therapy in early chronic renal failure.
    Bianchi ML; Colantonio G; Campanini F; Rossi R; Valenti G; Ortolani S; Buccianti G
    Nephrol Dial Transplant; 1994; 9(11):1595-9. PubMed ID: 7870349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol and calcium carbonate therapy in early chronic renal failure.
    Fournier A
    Nephrol Dial Transplant; 1995; 10(4):577. PubMed ID: 7624009
    [No Abstract]   [Full Text] [Related]  

  • 6. [Extensive intracranial calcification in chronic hypoparathyroidism].
    Jover-Díaz F; Pomares F; Matarranz M
    Rev Neurol; 2006 Jan 1-15; 42(1):61-2. PubMed ID: 16402330
    [No Abstract]   [Full Text] [Related]  

  • 7. Low doses of calcitriol or calcium carbonate for the prevention of hyperparathyroidism in predialysis patients?
    Fournier A; Oprisiu R; Moriniere P; El Esper N
    Nephrol Dial Transplant; 1996 Jul; 11(7):1493-5. PubMed ID: 8815432
    [No Abstract]   [Full Text] [Related]  

  • 8. [Osteodystrophies of chronic uremia].
    Meyrier A; Verger D; Richet G
    Schweiz Rundsch Med Prax; 1971 Dec; 60(50):1667-70. PubMed ID: 5140324
    [No Abstract]   [Full Text] [Related]  

  • 9. The approach to the treatment of secondary hyperparathyroidism in early renal failure.
    Fournier A; Morinière P; Renaud H
    Am J Nephrol; 1988; 8(2):170-2. PubMed ID: 3394724
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effect of vitamin D and calcium carbonate in renal osteomalacia.
    Eastwood JB; Bordier P; de Wardener HE
    Q J Med; 1971 Oct; 40(160):569-70. PubMed ID: 5157413
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of H2-blockers on serum calcium and phosphorus in hemodialysis patients on calcium carbonate therapy.
    Kushihata S; Yorioka N
    Clin Nephrol; 1998 Sep; 50(3):198-9. PubMed ID: 9776428
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medical parathyroidectomy. Its efficacy in treatment of lower maxillary brown tumor].
    Graciela Garcia M; Leanza H; Najun Zarazga C; Barreneche M
    Medicina (B Aires); 1996; 56(1):59-62. PubMed ID: 8734935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription of calcium carbonate to nondialyzed patients with a supranormal serum 1,25(OH)2D3 concentration.
    Okada K; Takahashi S; Nagura Y; Hatano M
    Nephron; 1991; 59(4):683-4. PubMed ID: 1766521
    [No Abstract]   [Full Text] [Related]  

  • 14. [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
    Caravaca F; Ruiz AB; Escola JM; Hernández Gallego R; Cerezo I; Fernández N; Barroso S; Martín MV
    Nefrologia; 2007; 27(4):466-71. PubMed ID: 17944584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of hypercalcaemia in haemodialysis patients.
    Pascual N; Andrea C; Zaleski M; Hernandez J; Goicoechea M
    EDTNA ERCA J; 1997; 23(3):48-50. PubMed ID: 9664010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium carbonate treatment of uremic acidosis.
    Berlyne GM
    Isr J Med Sci; 1971 Nov; 7(11):1235-9. PubMed ID: 5159605
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
    Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
    Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
    Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
    J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antacids.
    Stokes JF
    Practitioner; 1971 Jan; 206(231):35-8. PubMed ID: 5540192
    [No Abstract]   [Full Text] [Related]  

  • 20. Lanthanum: new drug. Hyperphosphataemia in dialysis patients: more potential problems than benefits.
    Prescrire Int; 2007 Apr; 16(88):47-50. PubMed ID: 17458039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.